# A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

> **NCT04544748** · PHASE1 · UNKNOWN · sponsor: **AO GENERIUM** · enrollment: 48 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Melanoma

## Interventions

- **BIOLOGICAL:** GNR-051

## Key facts

- **NCT ID:** NCT04544748
- **Lead sponsor:** AO GENERIUM
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-22
- **Primary completion:** 2022-11-07
- **Final completion:** 2025-01
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04544748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04544748, "A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04544748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*